RxDoctor Payments Data

Andrea Davis

Nurse Practitioner · Metairie, LANPI 1487178992

Payments from drug & device makers

$3,578in general payments, 2019–2025

Across 168 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$709
  • GSK$283
  • AstraZeneca$280
  • Novo Nordisk$226
  • Dexcom, Inc.$215
  • Idorsia Pharmaceuticals US Inc$201
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$3,48497%
  • Education$943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,578 in reported general payments places this provider in the 85th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$80,820
FarxigaDapagliflozin Propanediol32$37,878
MounjaroTirzepatide23$24,943
LinzessLinaclotide12$18,175
Omeprazole22$397
Diclofenac Sodium11$388
Fluticasone Propionate26$277
Atorvastatin Calcium58$262
Irbesartan17$255
Amlodipine Besylate44$249
Ibuprofen24$241
Gabapentin26$239
Memantine Hcl11$239
Metoprolol Succinate22$212
Zolpidem Tartrate30$192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$226$80,82050 claims
AstraZenecaFarxiga$280$37,87832 claims
Lilly USA, LLCMounjaro$74$24,94323 claims
AbbVieLinzess$709$18,17512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 969 nurse practitioner providers in Louisiana.

Other nurse practitioner in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →